Renal Cancers Completed Phase 3 Trials for Aldesleukin (DB00041)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00003126Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney CancerTreatment
NCT00018941Interleukin-2 in Treating Patients With Metastatic Kidney CancerTreatment
NCT00053820Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney CancerTreatment
NCT00053807Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney CancerTreatment
NCT00416871Interleukin-2 and Interferon in Treating Patients With Metastatic Kidney CancerTreatment
NCT00416429Medroxyprogesterone or Interferon and/or Aldesleukin in Treating Patients With Metastatic Kidney CancerTreatment